Skip to content

Evaluation of bleeding after endoscopic submucosal resection for colon polyps in patients taking antiplatelet or anticoagulant drugs

Evaluation of bleeding after endoscopic submucosal resection for colon polyps in patients taking antiplatelet or anticoagulant drugs - Evaluation of bleeding after endoscopic submucosal resection for colon polyps in patients taking antiplatelet or

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020455
Enrollment
500
Registered
2016-01-06
Start date
2016-04-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon polyps

Interventions

None listed

Sponsors

Aichi Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with colon polyps of less than 20mm and intramucosal lesion

Exclusion criteria

Exclusion criteria: Patients with severe comorbidities or polyps having invasion into submucosal layer

Design outcomes

Primary

MeasureTime frame
Frequency of bleeding after endoscopic submucosal resection

Secondary

MeasureTime frame
Complications besides bleeding after endoscopic submucosal resection

Countries

Japan

Contacts

Public ContactNaotaka Ogasawara

Aichi Medical University School of Medicine Department of Gastroenterology

nogasa@aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026